Fei Shen
8Patents
1h-index
29Co-inventors
47Inventor score
Filing activity: Apr 12, 2010 → Feb 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8404711B2 | 5-HT4 receptor agonist compounds for treatment of cognitive disorders | Human Necessities | 3 | Active |
| US12152036B2 | Substituted pyrrolo[1,2-α]quinoxalin-4(5H)-ones as CX3CR1 antagonists | Chemistry; Metallurgy | 0 | Active |
| US10517933B2 | Method of treating androgen receptor negative prostate tumors and their metastases | Physics | 0 | Active |
| US12077585B2 | Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses | Chemistry; Metallurgy | 0 | Active |
| US12365743B2 | Anti-CD28 x anti-PSMA antibodies | Chemistry; Metallurgy | 0 | Active |
| US12071466B2 | Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11267817B2 | Substituted pyrrolo[1,2-a]quinoxalin-4(5H)-ones as CX3CR1 antagonists | Chemistry; Metallurgy | 0 | Active |
| US12378326B2 | Anti-CD28 x anti-PSMA antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.